{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:46:38Z","timestamp":1761561998985},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,7,2]],"date-time":"2015-07-02T00:00:00Z","timestamp":1435795200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s00059-015-4325-0","type":"journal-article","created":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T08:11:38Z","timestamp":1435738298000},"page":"1070-1083","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Antithrombotic therapy after percutaneous coronary intervention in patients requiring oral anticoagulant treatment"],"prefix":"10.1007","volume":"40","author":[{"given":"Chao-Feng","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jue","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Zhou","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,2]]},"reference":[{"key":"4325_CR1","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1093\/eurheartj\/ehi426","volume":"26","author":"EG Butchart","year":"2005","unstructured":"Butchart EG, Gohlke-B\u00e4rwolf C, Antunes MJ et al (2005) Recommendations for the management of patients after heart valve surgery. Eur Heart J 26:2463\u20132471","journal-title":"Eur Heart J"},{"issue":"3","key":"4325_CR2","first-page":"234","volume":"9","author":"M Dabrowska","year":"2013","unstructured":"Dabrowska M et al (2013) Balancing between bleeding and thromboembolism after percutaneous coronary intervention in patients with atrial fibrillation. Could triple anticoagulant therapy be a solution? Postepy Kardiol Interwencyjnej 9(3):234\u2013240","journal-title":"Postepy Kardiol Interwencyjnej"},{"key":"4325_CR3","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/9780470693926.ch15","volume-title":"Systematic reviews in health care: meta-analysis in context","author":"JJ Deeks","year":"2001","unstructured":"Deeks JJ, Altman DG, Bradburn MJ (2001) Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Smith GD, Altman DG (eds) Systematic reviews in health care: meta-analysis in context, 2nd edn. BMJ Publishing Group, London, pp\u00a0285\u2013312","edition":"2"},{"issue":"5","key":"4325_CR4","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1592\/phco.27.5.691","volume":"27","author":"D DeEugenio","year":"2007","unstructured":"DeEugenio D et al (2007) Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy. Pharmacotherapy 27(5):691\u2013696","journal-title":"Pharmacotherapy"},{"key":"4325_CR5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177\u2013188","journal-title":"Control Clin Trials"},{"issue":"9872","key":"4325_CR6","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(12)62177-1","volume":"381","author":"WJ Dewilde","year":"2013","unstructured":"Dewilde WJ et al (2013) Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet 381(9872):1107\u20131115","journal-title":"Lancet"},{"issue":"5","key":"4325_CR7","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ahj.2013.08.005","volume":"166","author":"EL Fosbol","year":"2013","unstructured":"Fosbol EL et al (2013) Warfarin use among older atrial fibrillation patients with non-ST-segment elevation myocardial infarction managed with coronary stenting and dual antiplatelet therapy. Am Heart J 166(5):864\u2013870","journal-title":"Am Heart J"},{"issue":"4","key":"4325_CR8","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1253\/circj.CJ-09-0880","volume":"74","author":"F Gao","year":"2010","unstructured":"Gao F et al (2010) Comparison of different antithrombotic regimens for patients with atrial fibrillation undergoing drug-eluting stent implantation. Circ J 74(4):701\u2013708","journal-title":"Circ J"},{"issue":"4","key":"4325_CR9","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1253\/circj.CJ-09-0880","volume":"74","author":"F Gao","year":"2010","unstructured":"Gao F et al (2010) Meta-analysis of the combination of warfarin and dual antiplatelet therapy after coronary stenting in patients with indications for chronic oral anticoagulation. Circ J 74(4):701\u2013708","journal-title":"Circ J"},{"issue":"3","key":"4325_CR10","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.amjcard.2009.03.053","volume":"104","author":"M Gilard","year":"2009","unstructured":"Gilard M et al (2009) Antiplatelet therapy in patients with anticoagulants undergoing percutaneous coronary stenting (from STENTIng and oral antiCOagulants [STENTICO]). Am J Cardiol 104(3):338\u2013342","journal-title":"Am J Cardiol"},{"issue":"4","key":"4325_CR11","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1160\/TH09-10-0746","volume":"103","author":"L Gorin","year":"2010","unstructured":"Gorin L, Fauchier L, Nonin E, de Labriolle A, Haguenoer K, Cosnay P et al (2010) Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score =\u20091. Thromb Haemost 103(4):833\u2013840","journal-title":"Thromb Haemost"},{"key":"4325_CR12","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehr236","volume":"32","author":"CW Hamm","year":"2011","unstructured":"Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, Caso P, Dudek D, Gielen S, Huber K, Ohman M, Petrie MC, Sonntag F, Uva MS, Storey RF, Wijns W, Zahger D, ESC Committee for Practice Guidelines, Bax JJ, Auricchio A, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Knuuti J, Kolh P, McDonagh T, Moulin C, Poldermans D, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Torbicki A, Vahanian A, Windecker S, Document Reviewers, Windecker S, Achenbach S, Badimon L, Bertrand M, B\u00f8tker HE, Collet JP, Crea F, Danchin N, Falk E, Goudevenos J, Gulba D, Hambrecht R, Herrmann J, Kastrati A, Kjeldsen K, Kristensen SD, Lancellotti P, Mehilli J, Merkely B, Montalescot G, Neumann FJ, Neyses L, Perk J, Roffi M, Romeo F, Ruda M, Swahn E, Valgimigli M, Vrints CJ, Widimsky P (2011) ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 32:2999\u20133054","journal-title":"Eur Heart J"},{"key":"4325_CR13","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","volume":"146","author":"RG Hart","year":"2007","unstructured":"Hart RG, Pearce LA, Aguilar MI (2007) Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 146:857\u2013867","journal-title":"Ann Intern Med"},{"key":"4325_CR14","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1182\/blood.V99.9.3102","volume":"99","author":"J Hirsh","year":"2002","unstructured":"Hirsh J, Lee AY (2002) How we diagnose and treat deep vein thrombosis. Blood 99:3102\u20133110","journal-title":"Blood"},{"issue":"2","key":"4325_CR15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.cjca.2012.08.008","volume":"29","author":"KW Ho","year":"2013","unstructured":"Ho KW et al (2013) Antithrombotic therapy after coronary stenting in patients with nonvalvular atrial fibrillation. Can J Cardiol 29(2):213\u2013218","journal-title":"Can J Cardiol"},{"issue":"5","key":"4325_CR16","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.amjcard.2013.11.046","volume":"113","author":"DS Ice","year":"2014","unstructured":"Ice DS et al (2014) Unanswered questions in patients with concurrent atrial fibrillation and acute coronary syndrome. Am J Cardiol 113(5):888\u2013896","journal-title":"Am J Cardiol"},{"issue":"21","key":"4325_CR17","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","volume":"64","author":"CT January","year":"2014","unstructured":"January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW (2014) 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 64(21):e1\u201376","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"4325_CR18","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1093\/eurheartj\/ehl488","volume":"28","author":"PP Karjalainen","year":"2007","unstructured":"Karjalainen PP et al (2007) Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting. Eur Heart J 28(6):726\u2013732","journal-title":"Eur Heart J"},{"key":"4325_CR19","doi-asserted-by":"crossref","unstructured":"Kay GN, Le Huezey JY, Lowe JE, Olsson SB, Prystowsky EN, Tamago JL, Wann LS (2011) 2011 ACCF\/AHA\/HRS focused updates incorporated into the ACC\/AHA\/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines. Circulation 123:e269\u2013e367","DOI":"10.1161\/CIR.0b013e318214876d"},{"issue":"4","key":"4325_CR20","first-page":"162","volume":"18","author":"Z Khurram","year":"2006","unstructured":"Khurram Z et al (2006) Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding. J Invasive Cardiol 18(4):162\u2013164","journal-title":"J Invasive Cardiol"},{"issue":"2","key":"4325_CR21","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000089548","volume":"105","author":"Y Konstantino","year":"2006","unstructured":"Konstantino Y et al (2006) Aspirin, warfarin and a thienopyridine for acute coronary syndromes. Cardiology 105(2):80\u201385","journal-title":"Cardiology"},{"key":"4325_CR22","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1016\/j.jacc.2009.10.015","volume":"54","author":"FG Kushner","year":"2009","unstructured":"Kushner FG, Hand M, Smith SC Jr, King SB III, Anderson JL, Antman EM, Bailey SR, Bates ER, Blankenship JC, Casey DE Jr, Green LA, Hocman JS, Jacobs AK, Krumholz HM, Morrison DA, Ornato JP, Pearle DL, Peterson ED, Sloan MA, Whitlow PL, Williams DO (2009) 2009 focused updates: ACC\/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC\/AHA\/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 54:2205\u20132241","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"4325_CR23","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/CIRCULATIONAHA.112.114967","volume":"126","author":"M Lamberts","year":"2012","unstructured":"Lamberts M et al (2012) Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study. Circulation 126(10):1185\u20131193","journal-title":"Circulation"},{"issue":"11","key":"4325_CR24","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jacc.2013.05.029","volume":"62","author":"M Lamberts","year":"2013","unstructured":"Lamberts M et al (2013) Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention. J Am Coll Cardiol 62(11):981\u2013989","journal-title":"J Am Coll Cardiol"},{"key":"4325_CR25","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2011.08.007","volume":"58","author":"GN Levine","year":"2011","unstructured":"Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothou BK, Ting HH, ACCF, AHA, SCAI (2011) 2011 ACCF\/AHA\/SCAI Guideline for perctaneous coronary intervention: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol 58:e44\u2013e122","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"4325_CR26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1160\/TH09-08-0580","volume":"103","author":"GY Lip","year":"2010","unstructured":"Lip GY, Huber K, Andreotti F, Arnesen H, Airaksinen J, Cuisset T et al (2010) Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and\/or undergoing percutaneous coronary intervention stenting. Thromb Haemost 103(1):13\u201328","journal-title":"Thromb Haemost"},{"issue":"9","key":"4325_CR27","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s00063-008-1101-4","volume":"103","author":"L Maegdefessel","year":"2008","unstructured":"Maegdefessel L et al (2008) Anticoagulant and\/or antiplatelet treatment in patients with atrial fibrillation after percutaneous coronary intervention. A single-center experience. Med Klin (Munich) 103(9):628\u2013632","journal-title":"Med Klin (Munich)"},{"issue":"3","key":"4325_CR28","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1378\/chest.08-0350","volume":"134","author":"S Manzano-Fernandez","year":"2008","unstructured":"Manzano-Fernandez S et al (2008) Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting. Chest 134(3):559\u2013567","journal-title":"Chest"},{"issue":"3","key":"4325_CR29","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1540-8183.2005.04065.x","volume":"18","author":"SJ Mattichak","year":"2005","unstructured":"Mattichak SJ et al (2005) Evaluation of safety of warfarin in combination with antiplatelet therapy for patients treated with coronary stents for acute myocardial infarction. J Interv Cardiol 18(3):163\u2013166","journal-title":"J Interv Cardiol"},{"issue":"3","key":"4325_CR30","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1160\/TH07-11-0680","volume":"99","author":"AE May","year":"2008","unstructured":"May AE, Geisler T, Gawaz M (2008) Individualized antithrombotic therapy in high risk patients after coronary stenting. A double-edged sword between thrombosis and bleeding. Thromb Haemost 99(3):487\u2013493","journal-title":"Thromb Haemost"},{"issue":"4","key":"4325_CR31","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151(4):264\u2013269","journal-title":"Ann Intern Med"},{"issue":"4","key":"4325_CR32","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1161\/CIRCINTERVENTIONS.113.000179","volume":"6","author":"Y Naruse","year":"2013","unstructured":"Naruse Y et al (2013) Triple antithrombotic therapy is the independent predictor for the occurrence of major bleeding complications: analysis of percent time in therapeutic range. Circ Cardiovasc Interv 6(4):444\u2013451","journal-title":"Circ Cardiovasc Interv"},{"issue":"14","key":"4325_CR33","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1093\/eurheartj\/ehm186","volume":"28","author":"MC Nguyen","year":"2007","unstructured":"Nguyen MC et al (2007) Combining warfarin and antiplatelet therapy after coronary stenting in the Global Registry of Acute Coronary Events: is it safe and effective to use just one antiplatelet agent? Eur Heart J 28(14):1717\u20131722","journal-title":"Eur Heart J"},{"issue":"3","key":"4325_CR34","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ahj.2003.06.004","volume":"147","author":"JL Orford","year":"2004","unstructured":"Orford JL, Fasseas P, Melby S et al (2004) Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation. Am Heart J 147(3):463\u2013467","journal-title":"Am Heart J"},{"issue":"12","key":"4325_CR35","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/j.amjcard.2008.08.021","volume":"102","author":"R Rossini","year":"2008","unstructured":"Rossini R et al (2008) Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy. Am J Cardiol 102(12):1618\u20131623","journal-title":"Am J Cardiol"},{"issue":"2","key":"4325_CR36","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000086918","volume":"104","author":"A Rubboli","year":"2005","unstructured":"Rubboli A, Milandri M, Castelvetri C, Cosmi B (2005) Meta-analysis of trials comparing oral anticoagulation and aspirin versus dual antiplatelet therapy after coronary stenting. Clues for the management of patients with an indication for long-term anticoagulation undergoing coronary stenting. Cardiology 104(2):101\u2013106","journal-title":"Cardiology"},{"issue":"6","key":"4325_CR37","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1080\/07853890802089786","volume":"40","author":"A Rubboli","year":"2008","unstructured":"Rubboli A, Halperin JL, Airaksinen KE et al (2008) Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation. Ann Med 40(6):428\u2013436","journal-title":"Ann Med"},{"issue":"10","key":"4325_CR38","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.amjcard.2012.01.353","volume":"109","author":"A Rubboli","year":"2012","unstructured":"Rubboli A et al (2012) Antithrombotic management and 1-year outcome of patients on oral anticoagulation undergoing coronary stent implantation (from the Registro Regionale Angioplastiche Emilia-Romagna Registry). Am J Cardiol 109(10):1411\u20131417","journal-title":"Am J Cardiol"},{"issue":"6","key":"4325_CR39","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/clc.22254","volume":"37","author":"A Rubboli","year":"2014","unstructured":"Rubboli A et al (2014) One-year outcome of patients with atrial fibrillation undergoing coronary artery stenting: an analysis of the AFCAS registry. Clin Cardiol 37(6):357\u2013364","journal-title":"Clin Cardiol"},{"issue":"8","key":"4325_CR40","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jacc.2007.11.035","volume":"51","author":"JM Ruiz-Nodar","year":"2008","unstructured":"Ruiz-Nodar JM et al (2008) Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis. J Am Coll Cardiol 51(8):818\u2013825","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"4325_CR41","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1378\/chest.10-1408","volume":"139","author":"JM Ruiz-Nodar","year":"2011","unstructured":"Ruiz-Nodar JM, Mar\u00edn F, Manzano-Fern\u00e1ndez S, Valencia-Mart\u00edn J, Hurtado JA, Rold\u00e1n V et al (2011) An evaluation of the CHADS2 stroke risk score in patients with atrial fibrillation undergoing percutaneous coronary revascularization. Chest 139(6):1402\u20131409","journal-title":"Chest"},{"key":"4325_CR42","first-page":"253","volume":"126","author":"KJ Saheb","year":"2013","unstructured":"Saheb KJ, Deng BQ, Hu QS, Xie SL, Geng DF, Nie RQ (2013) Triple antithrombotic therapy versus double antiplatelet therapy after percutaneous coronary intervention with stent implantation in patients requiring chronic oral anticoagulation: a meta-analysis. Chin Med J 126:253\u2013242","journal-title":"Chin Med J"},{"issue":"18","key":"4325_CR43","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1136\/hrt.2009.167064","volume":"95","author":"A Sambola","year":"2009","unstructured":"Sambola A et al (2009) Therapeutic strategies after coronary stenting in chronically anticoagulated patients: the MUSICA study. Heart 95(18):1483\u20131488","journal-title":"Heart"},{"issue":"5","key":"4325_CR44","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-2796.2008.01989.x","volume":"264","author":"N Sarafoff","year":"2008","unstructured":"Sarafoff N et al (2008) Aspirin and clopidogrel with or without phenprocoumon after drug eluting coronary stent placement in patients on chronic oral anticoagulation. J Intern Med 264(5):472\u2013480","journal-title":"J Intern Med"},{"key":"4325_CR45","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1093\/eurheartj\/ehq172","volume":"31","author":"W Wijns","year":"2010","unstructured":"Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), European Association for Percutaneous Cardiovascular Interventions (EAPCI), Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J, LopezSendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, Taggart D (2010) Guidelines on myocardial revascularization. Eur Heart J 31:2501\u20132555","journal-title":"Eur Heart J"},{"key":"4325_CR46","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1001\/jama.288.19.2441","volume":"288","author":"C Walraven Van","year":"2002","unstructured":"Van Walraven C, Hart RG, Singer DE et al (2002) Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. JAMA 288:2441\u20132448","journal-title":"JAMA"},{"issue":"12","key":"4325_CR47","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.5603\/KP.2014.0224","volume":"72","author":"S Windecker","year":"2014","unstructured":"Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, J\u00fcni P, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann FJ, Richter DJ, Schauerte P, Uva MS, Stefanini GG, Taggart DP, Torracca L, Valgimigli M, Wijns W, Witkowski A (2014) 2014 ESC\/EACTS Guidelines on myocardial revascularization. Kardiol Pol 72(12):1253\u20131379","journal-title":"Kardiol Pol"},{"key":"4325_CR48","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1161\/CIR.0b013e31820f2f3e","volume":"123","author":"RS Wright","year":"2011","unstructured":"Wright RS, Anderson JL, Adams CD, Bridges CR, Casey DE Jr, Ettinger SM, Fesmire FM, Ganiats TG, Jneid H, Lincoff AM, Peterson ED, Philippides GJ, Theroux P, Wenger NK, Zidar JP, Jacobs AK (2011) ACCF\/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina\/Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Circulation 123:2022\u20132060","journal-title":"Circulation"},{"issue":"2","key":"4325_CR49","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1378\/chest.09-3083","volume":"139","author":"HJ Zhao","year":"2011","unstructured":"Zhao HJ, Zheng ZT, Wang ZH, Li SH, Zhang Y, Zhong M, Zhang W (2011) \u201cTriple therapy\u201d rather than \u201ctriple threat\u201d a meta-analysis of the two antithrombotic regimens after stent implantation in patients receiving long-term oral anticoagulant treatment. Chest 139(2):260\u2013270","journal-title":"Chest"},{"key":"4325_CR50","doi-asserted-by":"crossref","unstructured":"Denas G, Padayattil Jose S, Gresele P\u00a0et al (2013) Major bleeding in patients undergoing PCI and triple or dual\u00a0antithrombotic therapy: a parallel-cohort study.\u00a0J Thromb Thrombolysis 35:178\u2013184","DOI":"10.1007\/s11239-012-0790-y"}],"container-title":["Herz"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-015-4325-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00059-015-4325-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-015-4325-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T21:55:05Z","timestamp":1566942905000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00059-015-4325-0"}},"subtitle":["A meta-analysis"],"short-title":[],"issued":{"date-parts":[[2015,7,2]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["4325"],"URL":"https:\/\/doi.org\/10.1007\/s00059-015-4325-0","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,2]]}}}